2020: Our Extraordinary Year in DiDi Numbers
2020 was a year like no other for the world, for DiDi’s nearly 600 million users and driver partners, as well as its 13,000 corporate employees. At the dawn of a new year of hope, we would like to take some time to look back at some of the highlights in 2020 to celebrate the resilience of our people and cities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210128006172/en/
DiDi 2020 in Numbers (Graphic: Didi Chuxing)
- Protecting local communities is our utmost priority.
Offline, more than 11 million sets of free masks and sanitizers were distributed to millions of drivers and couriers worldwide throughout 2020. DiDi driver-managers helped install 1 million protective dividers in DiDi cars to prevent droplet infection. Hi-tech or low-tech, we went the full distance for tech that works.
Online, all of DiDi’s 30 million+ driver partners went through a Health Guard routine that includes mask, temperature and disinfection checks to log onto daily service.
We stand ready to help our cities. Globally, hundreds of thousands of DiDi drivers and couriers provided more than 6 million free or discounted rides and meals to frontline health care workers and those in need. From mask verification to contact tracing, our engineers open-sourced various technological tools for cities around the world.
- Our safety standards are higher and stronger.
Internationally, major safety incidents on DiDi dropped by 50.8% year-on-year. In-trip disputes and conflicts were down by 42.3%. Sexual-related complaints dropped by 71.4%.
This was made possible by continued safety investments. Across our international markets, DiDi’s risk analysis and management algorithms activated over 361 million control acts ranging from safety reminders, extra verifications, warnings and all the way to geo-fencing and active individual interventions.
But we couldn’t have done it without you and your safety awareness. Drivers and riders outside China chose to activate advanced safety options over 25 million times. In-trip audio recording was used over 1.3 million times. Over 23 million trips were shared with trusted ones.
- With these solid health and safety bottom lines, we helped build stronger and more inclusive communities.
Globally, over 4 million drivers and couriers registered to use DiDi’s platform in 2020, many of whom were looking for extra income opportunities to tackle the challenges arising from the pandemic. Of the newly registered driver partners in international markets in 2020, 13.6% are women. Together with our female employees that account for 40% of DiDi’s workforce, women drivers helped us build higher platform standards of diversity and inclusion.
- Together with these partners, we were able to stay resilient and achieve new growth.
Global daily trips hit a new record high of 60 million in October 2020. We also launched multiple new services including group-buying, courier, and freight businesses to capture demands arising from new consumer dynamics. As businesses focus more on efficiency, DiDi Enterprise Solutions, which helps cut employee and business transportation costs, also saw a 12% year-on-year growth in its client base.
In 2020, six new markets were opened – Russia, Peru, Panama, Argentina, the Dominican Republic and New Zealand. Trips completed outside China reached 1 billion.
-
Finally, our numbers also reflected special moments of life in every city we operate:
- Small businesses are true warriors: A food shop-owner in Brazil, our star user globally, completed 2,017 trips in 2020 for in-person delivery.
- There is always one long ride we have to take in life: A Brazilian user took a trip of 999.7 kilometers in 2020.
- Good food comforts us and makes things right: The most frequent DiDi Food user, a Mexican gourmet, completed 749 orders from 216 restaurants in 2020.
- The most popular time of the day to place a food delivery order was 3pm in Mexico, 7pm in Japan and 8pm in Brazil.
- In 2020, the most ordered items in Japan, Mexico and Brazil was large-size beef noodles, traditional pepperoni pizza, beef and chicken burger, respectively.
In times of uncertainty, we heard more stories of love, perseverance and our shared fighting spirit. Kudos to all! We will be back together, back stronger as 2021 brings renewed hopes and commitments.
About Didi Chuxing
Didi Chuxing (“DiDi”) is the world’s leading mobile transportation and local services platform. The company offers a full range of app-based services for over 550 million users across Asia Pacific, Latin America and Russia, including taxi-hailing, private car-hailing, P2P rideshare, bus, bikes & e-bikes, designated driving, automobile solutions, delivery and logistics, and financial services. Tens of millions of car owners, drivers and delivery partners who find flexible work and income opportunities on DiDi platform provide over 10 billion passenger trips a year. Daily trip volume for DiDi’s core mobility services exceeds 60 million during the first week of October 2020.
DiDi is committed to collaborating with policymakers, the taxi industry, the automobile industry and our communities to solve the world’s transportation, environmental and employment challenges with localized smart transportation innovations by leveraging its AI capabilities. We will strive non-stop to create better life experience and greater social value, through building a safe, inclusive and sustainable transportation and local services ecosystem for cities of the future.
For more information, please visit: www.didiglobal.com/news.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210128006172/en/
Contact information
Media Enquiry:
Didi Chuxing
globalpr@didiglobal.com
Sard Verbinnen & Co
DidiChuxing@sardverb.com
US +1 415 618 8750
HK +852 3842 2200
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
